iAnthus Capital (ITHUF) Stock Price, News & Analysis

Company Overview

iAnthus Capital Holdings Inc. is a multi-state operator in the U.S. cannabis industry, focusing on acquiring, developing and managing licensed cannabis cultivation, processing and dispensary facilities. Founded in 2013 and headquartered in New York, the company has built a diversified portfolio of retail and wholesale assets across several key medical and adult-use markets. iAnthus operates through wholly owned subsidiaries and strategic partnerships, delivering a range of cannabis products under proprietary brands and private-label agreements.

The company’s core business activities include cultivation of premium cannabis flower, extraction of cannabinoids for oils and concentrates, and manufacturing of edibles, tinctures and other derivative products. iAnthus’s vertically integrated model spans seed-to-sale operations, with cultivation facilities designed to optimize yield and quality, processing labs that adhere to rigorous safety standards, and dispensaries that provide patient-focused retail experiences. Key markets served include New York, Florida, Maryland, Massachusetts and Connecticut, among others.

Over the years, iAnthus has executed strategic acquisitions to expand its footprint and enhance operational scale. Notable transactions have included the purchase of established dispensary chains and cultivation sites, bolstering the company’s retail presence and capacity for product innovation. The company emphasizes compliance with state regulations and fosters community engagement through educational initiatives and charitable efforts in its host markets.

Leadership at iAnthus is spearheaded by CEO Hadley Ford, who brings extensive experience in capital markets and regulated industries. The executive team combines expertise in operations, finance and regulatory affairs to navigate the evolving landscape of U.S. cannabis legalization. With a commitment to responsible growth and quality standards, iAnthus Capital continues to pursue opportunities that align with its vision of delivering reliable access to cannabis products while driving long-term shareholder value.

Key Stats

• Today's Range: $0.0045 to $0.0050
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.02
• Volume: 539,874 shs
• Average Volume: 424,484 shs
• Market Capitalization: N/A
• P/E Ratio: 0.03
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iAnthus Capital Stock Analysis - MarketRank™

iAnthus Capital scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iAnthus Capital.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.01.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

iAnthus Capital has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iAnthus Capital has recently increased by 1.61%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iAnthus Capital does not currently pay a dividend.

Dividend Growth

iAnthus Capital does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

iAnthus Capital has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iAnthus Capital has recently increased by 1.61%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.80

News Sentiment

iAnthus Capital has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for iAnthus Capital this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for ITHUF on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iAnthus Capital insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.34% of the stock of iAnthus Capital is held by institutions.

ITHUF Stock Analysis - Frequently Asked Questions

How have ITHUF shares performed this year?

iAnthus Capital's stock was trading at $0.0048 at the start of the year. Since then, ITHUF stock has increased by 4.2% and is now trading at $0.0050.

How do I buy shares of iAnthus Capital?

Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:ITHUF
• CIK: 1643154
• Web: www.ianthuscapital.com
• Phone: 646-518-9411
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.03
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A